Fundraising Fox

TECLens

Stamford, US · Founded 2024 · Delaware corporation · 5 known investors

Find your way into TECLens

Healthtech

Founders & leadership

PLPatrick Lopath
Patrick LopathinChief Operating Officer
TA
Thomas Alan DunlapChief Executive Officer
MA
Madhu AyyagariChief Executive Officer
DE
David E. AckerSecretary

Board

RL
Richel LiuBoard director
DM
Deng MaoinBoard MemberInvestment Manager at Yonjin Venture LLC
HP
Hirak ParikhBoard director

Investors · 5

Johnson & Johnson Innovation – JJDCreportedNew Brunswick

Also in the syndicate · 4

Johnson & JohnsonleadRimonci CapitalSunmed CapitalYonjin Capitallead

Reported raises · per SEC filings

Form D private placements

$15.9M disclosed across 4 rounds · 2017–2026

▶$5.2MraisedJul 2026 · 6 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Madhu AyyagariExecutive Officer, Director
  • David E AckerExecutive Officer, Director
  • Patrick LopathExecutive Officer
  • Hirak ParikhDirector
  • Deng MaoDirector
  • Richel LiuDirector
Offering amount
$10.2M
Amount sold
$5.2M
First sale
Jul 2026
Incorporated
Corporation, Delaware, 2024
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$9.3MraisedMar 2025 · 4 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • David E. AckerExecutive Officer, Director
  • Patrick LopathExecutive Officer
  • Thomas Alan DunlapExecutive Officer, Director
  • Richel LiuDirector
  • Deng MaoDirector
  • Hirak ParikhDirector
Offering amount
$9.3M
Amount sold
$9.3M
Proceeds to insiders
$430.3K
First sale
May 2024
Incorporated
Corporation, Delaware, 2024
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$200KraisedFeb 2019 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • David AckerDirector
Offering amount
$1.5M
Amount sold
$200K
First sale
Feb 2019
Incorporated
Limited Liability Company, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.2MraisedJun 2017 · 3 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • David AckerDirector
Offering amount
$4M
Amount sold
$1.2M
First sale
May 2017
Incorporated
Limited Liability Company, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

CT-based biotech TECLens aims to make reading glasses optionalhartfordbusiness.com · Aug 2026TECLens study treats first patient for noninvasive refractive vision correctionglance.eyesoneyecare.com · Mar 2026TECLens Raises $9.3M for Refractive Technology | OBNophthalmologybreakingnews.com · Feb 2025CT medical device company raises $9.3M in Series A funding roundhartfordbusiness.com · Feb 2025TECLens Raises $9.3M Series A Fundingfinsmes.com · Feb 2025Johnson & Johnson Backs TECLens: Pushing Eye Care Forwardjjvision.com · Jun 2024

Frequently asked questions

Who are TECLens's investors?
TECLens's investors include Johnson & Johnson Innovation – JJDC.
How much funding has TECLens raised?
TECLens has disclosed $15.9M raised across 4 rounds.
Where is TECLens headquartered?
TECLens is headquartered in Stamford, US.